ICER Releases White Paper on Strategies to Address Payer Challenges Associated with Gene Therapies, Provides Needed Policy Reforms and Market Actions
April 23, 2024 | |
ICER Releases White Paper on Strategies to Address Payer Challenges Associated with Gene Therapies, Provides Needed Policy Reforms and Market Actions
The Institute for Clinical and Economic Review (ICER) and Tufts Medicine NEWDIGS released a white paper entitled “Managing the Challenges of Paying for Gene Therapy: Strategies for Market Action and Policy Reform.” ICER explains that it is the intent of the paper to call for thoughtful consideration of both market actions and policy reforms that have the potential to address… (Slifer, April 23, 2024) #Insurance Reform, #Pharmacy Benefit Managers, #Prescription Drugs
